Evaluation of disc diffusion and MIC testing for determining susceptibility of Pseudomonas aeruginosa isolates to topical enrofloxacin/silver sulfadiazine

Aust Vet J. 2007 Nov;85(11):464-6. doi: 10.1111/j.1751-0813.2007.00223.x.

Authors

D J Trott¹, S M Moss, A M See, R Rees

Affiliation

¹ School of Veterinary Science, The University of Queensland, St Lucia QLD 4072, Australia. d.trott@mailbox.uq.edu.au

PMID: 17970852
DOI: 10.1111/j.1751-0813.2007.00223.x

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Administration, Topical
Animals
Anti-Bacterial Agents / pharmacology*
Colony Count, Microbial / veterinary
Dog Diseases / drug therapy
Dog Diseases / microbiology
Dogs
Dose-Response Relationship, Drug
Drug Resistance, Bacterial
Drug Therapy, Combination
Enrofloxacin
Fluoroquinolones / pharmacology*
Otitis Media / drug therapy
Otitis Media / microbiology
Otitis Media / veterinary
Pseudomonas Infections / drug therapy
Pseudomonas Infections / microbiology
Pseudomonas Infections / veterinary*
Pseudomonas aeruginosa / drug effects*
Silver Sulfadiazine / pharmacology*

Substances

Anti-Bacterial Agents
Fluoroquinolones
Enrofloxacin
Silver Sulfadiazine